LncRNA ST8SIA6-AS1 Promotes Cholangiocarcinoma Progression by Suppressing the miR-145-5p/MAL2 Axis
Author:
Publisher
Informa UK Limited
Subject
Pharmacology (medical),Oncology
Reference41 articles.
1. Cancer statistics, 2019
2. Cholangiocarcinoma — evolving concepts and therapeutic strategies
3. Effects of caffeine and doxapram perfusion on local cerebral glucose utilization in conscious rats
4. Unique features of long non-coding RNA biogenesis and function
5. Long noncoding RNAs in cancer immunity: a new avenue in drug discovery
Cited by 11 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. ST8SIA6-AS1, a novel lncRNA star in liver cancer;Frontiers in Cell and Developmental Biology;2024-08-15
2. Clinical significance of lncRNA XIST expression in cholangiocarcinoma and its effect on cell migration and invasion;Clinics and Research in Hepatology and Gastroenterology;2024-08
3. Mitigating inflammatory response in breast cancer patients: the inhibitory effect of acupuncture and emotional nursing on the ST8SIA6-AS1/LINC00504/p38 pathway;Archives of Medical Science;2024-05-28
4. The Suppression of the Epithelial to Mesenchymal Transition in Prostate Cancer through the Targeting of MYO6 Using MiR-145-5p;International Journal of Molecular Sciences;2024-04-12
5. Research advances of MAL family members in tumorigenesis and tumor progression (Review);Molecular Medicine Reports;2024-02-14
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3